These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22505561)

  • 41. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.
    Gires O; Stoecklein NH
    Cell Mol Life Sci; 2014 Nov; 71(22):4393-402. PubMed ID: 25103341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms.
    Schmetzer O; Moldenhauer G; Nicolaou A; Schlag P; Riesenberg R; Pezzutto A
    Immunol Lett; 2012 Apr; 143(2):184-92. PubMed ID: 22387297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cysteine-poor region-specific EpCAM monoclonal antibody recognizing native tumor cells with high sensitivity.
    Takao M; Nagai Y; Torii T
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):73-80. PubMed ID: 23607341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.
    Sieuwerts AM; Kraan J; Bolt J; van der Spoel P; Elstrodt F; Schutte M; Martens JW; Gratama JW; Sleijfer S; Foekens JA
    J Natl Cancer Inst; 2009 Jan; 101(1):61-6. PubMed ID: 19116383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 49. Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging.
    Chen Q; Ge F; Cui W; Wang F; Yang Z; Guo Y; Li L; Bremner RM; Lin PP
    Clin Chim Acta; 2013 Apr; 419():57-61. PubMed ID: 23415723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling.
    Magbanua MJ; Park JW
    Methods; 2013 Dec; 64(2):114-8. PubMed ID: 23896286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans.
    Amann M; Friedrich M; Lutterbuese P; Vieser E; Lorenczewski G; Petersen L; Brischwein K; Kufer P; Kischel R; Baeuerle PA; Schlereth B
    Cancer Immunol Immunother; 2009 Jan; 58(1):95-109. PubMed ID: 18594818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model.
    Muhanna N; Mepham A; Mohamadi RM; Chan H; Khan T; Akens M; Besant JD; Irish J; Kelley SO
    Nanomedicine; 2015 Oct; 11(7):1613-20. PubMed ID: 25981337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces.
    Andree KC; Barradas AM; Nguyen AT; Mentink A; Stojanovic I; Baggerman J; van Dalum J; van Rijn CJ; Terstappen LW
    ACS Appl Mater Interfaces; 2016 Jun; 8(23):14349-56. PubMed ID: 27187784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EpCAM associates with endoplasmic reticulum aminopeptidase 2 (ERAP2) in breast cancer cells.
    Gadalla SE; Öjemalm K; Vasquez PL; Nilsson I; Ericsson C; Zhao J; Nistér M
    Biochem Biophys Res Commun; 2013 Sep; 439(2):203-8. PubMed ID: 23988446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection.
    Hager G; Cacsire-Castillo Tong D; Schiebel I; Rezniczek GA; Watrowski R; Speiser P; Zeillinger R
    Gynecol Oncol; 2005 Aug; 98(2):211-6. PubMed ID: 15967487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carboxybetaine methacrylate oligomer modified nylon for circulating tumor cells capture.
    Dong C; Wang H; Zhang Z; Zhang T; Liu B
    J Colloid Interface Sci; 2014 Oct; 432():135-43. PubMed ID: 25086387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
    Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
    Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.
    Saucedo-Zeni N; Mewes S; Niestroj R; Gasiorowski L; Murawa D; Nowaczyk P; Tomasi T; Weber E; Dworacki G; Morgenthaler NG; Jansen H; Propping C; Sterzynska K; Dyszkiewicz W; Zabel M; Kiechle M; Reuning U; Schmitt M; Lücke K
    Int J Oncol; 2012 Oct; 41(4):1241-50. PubMed ID: 22825490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy.
    Simon M; Stefan N; Plückthun A; Zangemeister-Wittke U
    Expert Opin Drug Deliv; 2013 Apr; 10(4):451-68. PubMed ID: 23316711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.